Higgins-Dun rejoining CNBC to cover pharma and health

Noah Higgins-Dunn

FiercePharma reporter Noah Higgins-Dunn is returning to CNBC.com to cover pharmaceuticals and health.

He had joined FiercePharma earlier this year. He will start at CNBC next week.

Higgins-Dunn was a digital associate for CNBC.com covering the coronavirus. As a health and science reporter, he has covered breaking national news from the Trump administration and pharmaceutical companies racing to develop and produce COVID-19 therapeutics and vaccines.

His reporting on the opportunity gap within a mid-Missouri school district won two awards from the Missouri Press Association for best local business coverage and feature writing. He has also won a Missouri APME Award for Spot News from The Associated Press.

Higgins-Dunn graduated magna cum laude from the University of Missouri in 2019, earning a bachelor’s degree in journalism with an emphasis in business and economics reporting and a minor in business.

Chris Roush

Chris Roush was the dean of the School of Communications at Quinnipiac University in Hamden, Connecticut. He was previously Walter E. Hussman Sr. Distinguished Professor in business journalism at UNC-Chapel Hill. He is a former business journalist for Bloomberg News, Businessweek, The Atlanta Journal-Constitution, The Tampa Tribune and the Sarasota Herald-Tribune. He is the author of the leading business reporting textbook "Show me the Money: Writing Business and Economics Stories for Mass Communication" and "Thinking Things Over," a biography of former Wall Street Journal editor Vermont Royster.